Celcuity Inc.
NASDAQ:CELCBiotechnology
-$4.04 today
- Market cap
- $2.72B
- Beta
- 0.12
- P/E (TTM)
- -23.7
- EPS (TTM)
- -$3.54
Volume 0.98M
Average 1.24M
CELC Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Celcuity Inc.NASDAQ: CELC
Net Change in Cash · Q2 FY2026 · quarter ended Jun 2026
Net change in cash grows, but more slowly than its trailing trend
Q2 FY2026 net change in cash of $36.86M rose 23.4% year over year, behind the +753.7% change in trailing-twelve-month net change in cash.
Context
- Net change in cash increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +23.4% toward the trailing-twelve-month pace of +753.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 143.19M USD
- Year-over-year change
- +1857.4%
- 4-year CAGR
- +18.5%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 143.19M | +1857.4% |
| FY2024 | 2024-12-31 | (8.15M) | -233.8% |
| FY2023 | 2023-12-31 | 6.09M | +110.2% |
| FY2022 | 2022-12-31 | (59.71M) | -182.2% |
| FY2021 | 2021-12-31 | 72.65M | — |
Net Change in Cash vs competitors
How CELC compares with its peers on the latest reported figures
- CELC's LTM Jun 2026 net change in cash of $135.7M is the 2nd largest of the 6 companies compared; the peer median is $2.59M.
- Its year-over-year change of +753.7% is the 2nd highest of 5, against a peer median of -92.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BLLNBillionToOne, Inc. | LTM Jun 2026 | $359.67M | — | — | 90.5% |
| LTM Jun 2026 | $135.7M | +753.7% | — | — | |
| LTM Jun 2026 | $126.75M | +857.5% | — | 41.1% | |
| LTM Mar 2026 | $25.93M | -484.6% | -75.7% | 7.6% | |
| LTM Jun 2026 | $9.18M | -95.4% | +56.9% | 1.2% | |
| LTM Mar 2026 | $2.59M | -90.4% | — | 4.0% | |
| Peer median (excluding CELC) | $2.59M | -92.9% | -9.4% | 7.6% | |
Competitors are the stored peer set for CELC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Depreciation & Amortization | 303.24K | 210.92K | 142.77K | 129.95K | 167K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.61M | 4.64M | 4.9M | 6.99M | 21.38M |
| Change in Working Capital | 819.81K | (1.19M) | 3.86M | 18.35M | (2.65M) |
| Accounts Receivables | (108.76K) | 95.1K | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.31M | 1.08M | 2.43M | 4.32M | (3.04M) |
| Other Working Capital | (377.36K) | (2.36M) | 1.43M | 14.03M | 388K |
| Other Non-Cash Items | 5.56M | 704.66K | 1.06M | 2.85M | 4.86M |
| Operating Cash Flow | (20.31M) | (36.01M) | (53.81M) | (83.47M) | (153.28M) |
| Capital Expenditures | (81.9K) | (158.77K) | (97.64K) | (249.88K) | (249K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (143.87M) | (314.53M) | (705.16M) | (396.34M) |
| Sales of Investments | 0 | 0 | 309.61M | 642.35M | 332.51M |
| Other Investing Activities | 500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (81.4K) | (144.03M) | (5.01M) | (63.07M) | (64.08M) |
| Debt Repayment | 14.34M | 19.5M | (2.45K) | 59.23M | 222.75M |
| Common Stock Issued | 78.55M | 100.5M | 14.43M | 63.61M | 137.85M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 148.02K | 324.12K | 50.48M | 15.55M | (46K) |
| Financing Cash Flow | 93.04M | 120.33M | 64.91M | 138.39M | 360.55M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 177 |
| Net Change in Cash | 72.65M | (59.71M) | 6.09M | (8.15M) | 143.19M |
| Free Cash Flow | (20.39M) | (36.17M) | (53.91M) | (83.72M) | (153.53M) |
Celcuity Inc.
NASDAQ:CELC
Intrinsic Alpha fair value
Locked
Current Price
$55.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.